Skip to content
OpenCapital
Get started

Jade Biosciences, Inc. Common Stock JBIO Business Segments

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Research And Development Expense by Business
JADE101$15.42M+57.9%$5.89M-74.4%$6.04M-52.5%$7.25M—$9.77M—
JADE201$2.88M-44.2%$4.02M+64.9%$6.72M+2,495%$8.36M—$5.15M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Jade Biosciences, Inc. Common Stock break its business down?
Jade Biosciences, Inc. Common Stock (JBIO) reports research and development expense by business across 2 parts — JADE101 and JADE201. Each is extracted from the segment footnotes and tracked over time.
Where does Jade Biosciences, Inc. Common Stock's segment data come from?
Segment breakdowns are pulled from the segment footnotes in Jade Biosciences, Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.